Patent application number | Description | Published |
20100136111 | PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL - The present invention relates to pharmaceutical compositions of diclofenac or pharmaceutically acceptable salts thereof and misoprostol or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparations of such compositions. | 06-03-2010 |
20100196471 | NOVEL TABLET DOSAGE FORM - The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients. | 08-05-2010 |
20110166225 | ORAL LIQUID COMPOSITIONS OF RHEIN OR DIACEREIN - The invention relates to liquid pharmaceutical compositions for oral administration comprising rhein or diacerein, or salts or esters or prodrugs thereof and processes for preparing such compositions. | 07-07-2011 |
20120070492 | RHEIN OR DIACEREIN COMPOSITIONS - The invention relates to pharmaceutical compositions comprising rhein or diacerein or salts or esters or prodrugs thereof, optionally with one or more pharmaceutically acceptable excipients. The invention also relates to the methods for preparing such compositions. | 03-22-2012 |
Patent application number | Description | Published |
20100285114 | PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN - The invention relates to pharmaceutical compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50®. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools as compared to Art 50®. The invention also relates to the methods for preparing such compositions. | 11-11-2010 |
20100285126 | PHARMACEUTICAL COMPOSITIONS OF FENOFIBRATE - The invention relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more pharmaceutically acceptable vehicles. The invention also relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more cyclodextrin derivatives. The invention also relates to processes for the preparation of such compositions. | 11-11-2010 |
20110086070 | Orally disintegrating compositions of rhein or diacerein - The invention relates to orally disintegrating pharmaceutical compositions comprising rhein or diacerein, or salts or esters or prodrugs thereof, and processes for preparing such compositions. | 04-14-2011 |
20150079170 | NOVEL TABLET DOSAGE FORM - The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients. | 03-19-2015 |
Patent application number | Description | Published |
20150238451 | Pharmaceutical compositions of diclofenac or salts thereof - The present invention refers to an improved pharmaceutical composition of diclofenac or pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein the composition is substantially free of solubilizing agents. By judicially using pharmaceutical excipients other than solubilizing agent, pharmaceutical composition of diclofenac or its salts with rapid and uniform gastrointestinal absorption of diclofenac can be achieved. The composition of the invention can also minimize the controllable side effects of diclofenac. | 08-27-2015 |
20150250750 | PHARMACEUTICAL COMPOSTIONS OF DICLOFENAC OR SALTS THEREOF - The present invention refers to an improved pharmaceutical composition of diclofenac or pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein the composition is substantially free of dispersing agents. By judicially using pharmaceutical excipients other than dispersing agent, pharmaceutical composition of diclofenac or its salts with rapid and uniform gastrointestinal absorption of diclofenac can be achieved. The composition of the invention can also minimize the controllable side effects of diclofenac. | 09-10-2015 |
20150250751 | PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC OR SALTS THEREOF - The present invention refers to an improved pharmaceutical composition of diclofenac or pharmaceutically acceptable salt comprising dispersing agent and pharmaceutically acceptable excipients. The invention relates to pharmaceutical composition of diclofenac or pharmaceutically acceptable salt and lower amount of dispersing agents. By administering such composition, rapid and uniform gastrointestinal absorption of diclofenac can be achieved. The invention also includes process of preparing such composition. | 09-10-2015 |
20150366850 | Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof - The present invention relates to a modified release pharmaceutical composition of dexmethylphenidate or salts thereof. In particular, the present invention relates to a modified release pharmaceutical composition comprising plurality of components exhibiting both immediate and extended release of dexmethylphenidate or salts thereof. The composition may provide therapeutically effective plasma concentration over a period of 24 hours to treat attention deficit hyperactivity disorder when administered to a patient in need thereof. The invention also includes process of preparing such composition. | 12-24-2015 |